NeuroPace, Inc.
NASDAQ:NPCE
Overview | Financials
Company Name | NeuroPace, Inc. |
Symbol | NPCE |
Currency | USD |
Price | 11.84 |
Market Cap | 353,401,504 |
Dividend Yield | 0% |
52-week-range | 5.45 - 18.15 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Joel D. Becker |
Website | https://www.neuropace.com |
An error occurred while fetching data.
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD